Teva CEO Schultz: ‘Proof Is In The Pudding’ For US Biosimilars
Biosimilars Key For Teva As It Chases Mid-Single Digit Sales Growth
Teva is "very happy about the situation we see in the biosimilar space," according to CEO Kåre Schultz • Source: Shutterstock 
